Skip to main content

Advertisement

SpringerLink
Log in

Ranibizumab for retinal arterial macroaneurysms

  • Letter to the Editor
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wenkstern AR, Petersen H (2010) Intravitreal ranibizumab in retinal macroaneurysm. Graefes Arch Clin Exp Ophthalmol. doi:10.1007/s00417-010-1380-3

    PubMed  Google Scholar 

  2. Chew EY, Murphy RP (2005) Acquired retinal macroaneurysms. In: Ryan SJ (ed) Retina. vol 2; Medical retina. Mosby, St. Louis, pp 1499–1502

    Google Scholar 

  3. Lewis RA, Norton EW, Gass JD (1976) Acquired arterial macroaneurysms of the retina. Br J Ophthalmol 60:21–30

    Article  PubMed  CAS  Google Scholar 

  4. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, Marina Study Group (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431

    Article  PubMed  CAS  Google Scholar 

  5. Rouvas A, Petrou P, Vergados I, Pechtasides D, Liarakos V, Mitsopoulou M, Ladas I (2009) Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: a pilot study. Graefes Arch Clin Exp Ophthalmol 247:1609–1616

    Article  PubMed  CAS  Google Scholar 

  6. Chanana B, Azad RV (2009) Intravitreal bevacizumab for macular edema secondary to retinal macroaneurysm. Eye 23:493–494

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, University Hospital La Fe, Valencia, Spain

    Roberto Gallego-Pinazo, Sebastián Martínez-Castillo & Manuel Díaz-Llopis

  2. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Valencia, Spain

    Roberto Gallego-Pinazo & Manuel Díaz-Llopis

  3. Retina & Vitreous Service, Clínica Oftalmológica Centro Caracas, Caracas, Venezuela

    J. Fernando Arévalo

  4. Faculty of Medicine, University of Valencia, Valencia, Spain

    Manuel Díaz-Llopis

  5. Avenida de Campanar, 21., 46009, Valencia, Spain

    Roberto Gallego-Pinazo

Authors
  1. Roberto Gallego-Pinazo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sebastián Martínez-Castillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Fernando Arévalo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Manuel Díaz-Llopis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roberto Gallego-Pinazo.

Additional information

The authors have no financial interest to disclose.

The authors have full control of all primary data, and they agree to allow Graefe’s Archive for Clinical and Experimental Ophthalmology to review their data if requested.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gallego-Pinazo, R., Martínez-Castillo, S., Arévalo, J.F. et al. Ranibizumab for retinal arterial macroaneurysms. Graefes Arch Clin Exp Ophthalmol 249, 1267–1268 (2011). https://doi.org/10.1007/s00417-010-1543-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-010-1543-2

Keywords

Search

Navigation